The promise of novel direct oral anticoagulants

被引：22
作者：
Hoffman, Ron [1 ,2 ]
Brenner, Benjamin
机构：
[1] Rambam Hlth Care Campus, Dept Hematol & Bone Marrow Transplantat, In Patient Hematol Unit, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, In Patient Hematol Unit, IL-31096 Haifa, Israel
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2012年 / 25卷 / 03期
关键词：
thromboembolism; new anticoagulants; direct thrombin inhibitors; factor Xa inhibitors; NONVALVULAR ATRIAL-FIBRILLATION; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; DOUBLE-BLIND; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; PREDICTING STROKE; KNEE REPLACEMENT;
D O I：
10.1016/j.beha.2012.06.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The standard effective treatment of venous and arterial thromboembolism includes unfractionated and low-molecular weight heparin as well as warfarin, which have major disadvantages. In recent years, new anticoagulants have been developed in an attempt to overcome the known limitations of established treatment and develop improved therapies. This chapter reviews pharmacological properties of the new anticoagulants, the most recent trials assessing their safety and efficacy as well as potential advantages and disadvantages of using these novel drugs in real life. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：351 / 360
页数：10
相关论文
共 65 条
  • [21] Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial
    Eriksson, B. I.
    Dahl, O. E.
    Rosencher, N.
    Kurth, A. A.
    Van Dijk, N.
    Frostick, S. P.
    Kalebo, P.
    Christiansen, A. V.
    Hantel, S.
    Hettiarachchi, R.
    Schnee, J.
    Buller, H. R.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (11) : 2178 - 2185
  • [22] Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
    Eriksson, Bengt I.
    Borris, Lars C.
    Friedman, Richard J.
    Haas, Sylvia
    Huisman, Menno V.
    Kakkar, Ajay K.
    Bandel, Tiemo J.
    Beckmann, Horst
    Muehlhofer, Eva
    Misselwitz, Frank
    Geerts, William
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (26) : 2765 - 2775
  • [23] Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement:: a randomised, double-blind, non-inferiority trial
    Eriksson, Bengt I.
    Dahl, Ola E.
    Rosencher, Nadia
    Kurth, Andreas A.
    van Dijk, C. Niek
    Frostick, Simon P.
    Prins, Martin H.
    Hettiarachchi, Rohan
    Hantel, Stefan
    Schnee, Janet
    Bueller, Harry R.
    [J]. LANCET, 2007, 370 (9591) : 949 - 956
  • [24] Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
    Eriksson, Bengt I.
    Quinla, Datfiel J.
    Weitz, Jeffrey I.
    [J]. CLINICAL PHARMACOKINETICS, 2009, 48 (01) : 1 - 22
  • [25] Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis -: A randomized trial
    Fiessinger, JN
    Huisman, MV
    Davidson, BL
    Bounameaux, H
    Francis, CW
    Eriksson, H
    Lundström, T
    Berkowitz, SD
    Nyström, P
    Thorsén, M
    Ginsberg, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 681 - 689
  • [26] Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement
    Francis, CW
    Berkowitz, SD
    Comp, PC
    Lieberman, JR
    Ginsberg, JS
    Paiement, G
    Peters, GR
    Roth, AW
    McElhattan, J
    Colwell, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (18) : 1703 - 1712
  • [27] Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
    Gage, BF
    Waterman, AD
    Shannon, W
    Boechler, M
    Rich, MW
    Radford, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22): : 2864 - 2870
  • [28] Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
    Ginsberg, Jeffrey S.
    Davidson, Bruce L.
    Comp, Philip C.
    Francis, Charles W.
    Friedman, Richard J.
    Hue, Michael H.
    Lieberman, Jay R.
    Muntz, James E.
    Raskob, Gary E.
    Clements, Mary L.
    Hentel, Stefan
    Schnee, Janet M.
    Caprini, Joseph A.
    [J]. JOURNAL OF ARTHROPLASTY, 2009, 24 (01) : 1 - 9
  • [29] Goldhaber S.Z., 2011, N ENGL J MED
  • [30] Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1
    Gorin, Laurent
    Fauchier, Laurent
    Nonin, Emilie
    de Labriolle, Axel
    Haguenoer, Ken
    Cosnay, Pierre
    Babuty, Dominique
    Charbonnier, Bernard
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) : 833 - 840
1234567